ACRS
NASDAQ · Pharmaceuticals
Aclaris Therapeutics Inc
$4.41
+0.07 (+1.61%)
Open$4.35
Previous Close$4.34
Day High$4.46
Day Low$4.26
52W High$4.89
52W Low$1.16
Volume—
Avg Volume1.33M
Market Cap687.15M
P/E Ratio—
EPS$-0.53
SectorPharmaceuticals
Analyst Ratings
Strong Buy
16 analysts
Price Target
+303.4% upside
Current
$4.41
$4.41
Target
$17.79
$17.79
$13.99
$17.79 avg
$22.90
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 9.96M | 15.54M | 98.24M |
| Net Income | -82,535,343 | -115,938,518 | 16.97M |
| Profit Margin | -829.6% | -788.1% | 17.3% |
| EBITDA | -91,666,117 | -135,918,231 | 25.23M |
| Free Cash Flow | — | — | 16.84M |
| Rev Growth | -35.9% | -35.9% | +7.1% |
| Debt/Equity | — | — | 1.07 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |